{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:09Z","timestamp":1761058629868},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":5458,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1991,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anticardiolipin antibodies (ACA) and lupus\u2010like anticoagulant (LLAC) have been studied in a group of 142 non\u2010hospitalized and a group of 72 hospitalized HIV infected patients. We observed a variable frequency of ACA positivity ranging from 7.7% to 30.3% according to the groups of patients and the isotype of immunoglobulin fraction containing ACA activity. None of the patients investigated presented a prolongation of the activated partial thromboplastin time (APTT) compatible with the presence of a LLAC. Some patients presented a weak anticoagulant activity only detected by the tissue thromboplastin inhibition (TTI) test. No positive correlation was found between this latter test and ACA. We conclude that, like in syphilitic patients, ACA present in HIV infected patients are most often not associated with LLAC.<\/jats:p>","DOI":"10.1002\/ajh.2830370404","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T12:49:21Z","timestamp":1172062161000},"page":"234-238","source":"Crossref","is-referenced-by-count":10,"title":["Anticardiolipin antibodies (ACA) are most often not associated with lupus\u2010like anticoagulant (LLAC) in human immunodeficiency virus (HIV) infection"],"prefix":"10.1002","volume":"37","author":[{"given":"P.","family":"Capel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Clumeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Feremans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vandevelde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fondu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-2-175"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380040065030"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb06206.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1001\/archinte.1989.00390080091020","article-title":"Anticardiolipin antibodies in acquired immunodeficiency syndrome","volume":"149","author":"Stimmler MM","year":"1989","journal-title":"Arch Intern Med:"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood.V48.4.499.499","article-title":"A clinical study of the lupus anticoagulant","volume":"48","author":"Schleider MA","year":"1976","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1978.tb03648.x"},{"key":"e_1_2_1_8_2","first-page":"738","article-title":"Measurement of anticardiolipin antibodies by an enzyme linked immunosorbant assay (ELISA) standardization and quantitation of results","volume":"62","author":"Loizou S","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb06207.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199005000-00011"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb04157.x"},{"key":"e_1_2_1_12_2","first-page":"215","article-title":"Evaluation of the anti\u2010cardiolipin antibody test: report of an international workshop held 4 April 1986","volume":"68","author":"Harris EN","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07687.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(89)90359-1"},{"key":"e_1_2_1_15_2","first-page":"141","volume-title":"The medical management of AIDS","author":"Cello JP","year":"1988"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-429_2"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-5-771_1"},{"key":"e_1_2_1_18_2","first-page":"405","article-title":"Les anticoagulants circulants au cours de \u013einfection par le virus de \u013eimmunod\u00e9ficience humdine","volume":"140","author":"Taillan B","year":"1989","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198605083141913"},{"key":"e_1_2_1_20_2","first-page":"120","article-title":"The sensitivity of different coagulation reagents to the presence of lupus anticoagulants","volume":"111","author":"Brandt JT","year":"1987","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(87)90354-3"},{"key":"e_1_2_1_22_2","first-page":"105","article-title":"The occurrence of circulating anticoagulants in patients with syphilitic and biologically false positive antilipoidal antibodies","volume":"60","author":"Johansson EA","year":"1974","journal-title":"Ann Clin Res"},{"key":"e_1_2_1_23_2","first-page":"449","article-title":"Antiphospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity","volume":"59","author":"Cola\u00e7o CB","year":"1985","journal-title":"Clin Exp Immunol"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830370404","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830370404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T09:34:11Z","timestamp":1698053651000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830370404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,8]]}},"alternative-id":["10.1002\/ajh.2830370404"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830370404","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,8]]}}}